Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-13

Clinical Trial Update: Effect of Oral Supplementation With Curcumin in Patients With Proteinuric Diabetic Kidney Disease [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating oral curcumin supplementation in patients with proteinuric diabetic nephropathy, with the study status currently unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez | Conditions: Proteinuria | Phase 2 | Status: UNKNOWN